Market Research Logo

Myanmar Pharmaceuticals & Healthcare Q3 2018

Myanmar Pharmaceuticals & Healthcare Q3 2018

BMI View:

The new Myanmar Companies Act marks one of the biggest changes in Myanmar's regulatory landscape - seeking toopen up previously closed sections of Myanmar's economy to foreign investment including for the medical equipment andpharmaceuticals sectors. The new law will likely provide a boost to increase pharmaceutical FDI and will likely see foreign inflowspick up gradually over the coming quarters. The act will also foster growth in small to medium enterprises, including in healthcare,resulting in greater foreign-domestic partnerships and joint ventures, and boosting the transfer of skills and capital into theMyanmar economy.


BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Pharmaceuticals: Divergent Regional Trends Will Shape Drugmaker Opportunities
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Mega Lifesciences
Fame Pharmaceutical
Demographic Forecast
Myanmar - Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report